Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial

Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial

Detaylı Bibliyografya
Asıl Yazarlar:	Wechsler, M, Akuthota, P, Jayne, D, Khoury, P, Klion, A, Langford, C, Merkel, P, Moosig, F, Specks, U, Cid, M, Luqmani, R, Brown, J, Mallett, S, Philipson, R, Yancey, S, Steinfeld, J, Weller, P, Gleich, G
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	American Thoracic Society 2017

Benzer Materyaller

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
Yazar:: Wechsler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
Yazar:: Wechsler, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
Yazar:: Benjamin Terrier, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
Yazar:: Ravi Ranjan Pradhan, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
Yazar:: Giuseppe A. Ramirez, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis
Yazar:: Falk, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
Yazar:: Falk, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
Yazar:: Falk, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
Yazar:: Falk, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis
Yazar:: Jessy Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis
Yazar:: Moriyasu Anai, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
Yazar:: Masanobu Ueno, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings
Yazar:: Takaharu Ikeda, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
Yazar:: Charlene Desaintjean, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

The effects of mepolizumab on peripheral circulation and neurological symptoms in eosinophilic granulomatosis with polyangiitis (EGPA) patients
Yazar:: Noboru Kitamura, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
Yazar:: Sujit Surendran, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
Yazar:: Andrea Portacci, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis
Yazar:: Nami Masumoto, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation
Yazar:: Mari Sato, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
Yazar:: Masanobu Ueno, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Yazar:: Christian Dejaco, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis.
Yazar:: Rennie L Rhee, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

A Case of Effective Mepolizumab Induction Therapy for Severe Eosinophilic Granulomatosis with Polyangiitis Diagnosed by Eosinophilic Cholecystitis and Interstitial Nephritis
Yazar:: Keita Hattori, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Efficacy and safety of belimumab in combination with azathioprine for remission maintenance in granulomatosis with polyangiitis and microscopic polyangiitis: a multicenter randomized, placebo-controlled study
Yazar:: Jayne, D, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Reduction in ANCA levels associated with mepolizumab add-on treatment in eosinophilic granulomatosis with polyangiitis: Case series and literature review
Yazar:: Yosuke Kamide, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission
Yazar:: B. Cremonezi Lammoglia, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics
Yazar:: David R.W. Jayne, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
Yazar:: Michele V. Quan, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

Eosinophilic granulomatosis with polyangiitis: an overview
Yazar:: Andrea eGioffredi, ve diğerleri
Baskı/Yayın Bilgisi: (2014-11-01)

Update on eosinophilic granulomatosis with polyangiitis
Yazar:: Shunsuke Furuta, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

A MODEL TO PREDICT CARDIOVASCULAR EVENTS IN PATIENTS WITH NEWLY DIAGNOSED WEGENER'S GRANULOMATOSIS AND MICROSCOPIC POLYANGIITIS
Yazar:: Suppiah, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.
Yazar:: Merkel, P, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
Yazar:: David Jayne, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis by Additional Mepolizumab
Yazar:: Shin-ya Tamechika, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Ophthalmologic manifestations of granulomatosis with polyangiitis (Wegener’s granulomatosis)
Yazar:: Ya O Grusha, ve diğerleri
Baskı/Yayın Bilgisi: (2015-12-01)

Clinical Manifestations and Long‐Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America
Yazar:: Irena Doubelt, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Granulomatosis with polyangiitis
Yazar:: Yu Zhu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Granulomatosis with polyangiitis
Yazar:: Zubayer Ahmad, ve diğerleri
Baskı/Yayın Bilgisi: (2016-12-01)

Nasal Cytology in Eosinophilic Granulomatosis with Polyangiitis
Yazar:: David Longhino, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Burden of eosinophilic granulomatosis with polyangiitis in Europe
Yazar:: Rupert W. Jakes, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)